Supplemental Table 3 shows overlapping gene sets contributing to KEGG pathway enrichment between acquired resistant PDX models and relapsed AML patients.
No takes yet. Share an insight, caveat, or question.
Olesinski et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: